# Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity

> **NCT05181514** · NA · COMPLETED · sponsor: **Azienda Ospedaliero, Universitaria Pisana** · enrollment: 12 (actual)

## Conditions studied

- Hypertriglyceridemia
- Glucose Intolerance

## Interventions

- **OTHER:** 20% Intralipid
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT05181514
- **Lead sponsor:** Azienda Ospedaliero, Universitaria Pisana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05181514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05181514, "Impact of Plasma Lipids on β Cell Function and Insulin Sensitivity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05181514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*